Skip to main content

20-05-2019 | Asthma | Video

ATS 2019: Many patients with mild asthma have low eosinophil levels

Stephen Lazarus outlines findings from the SIENA crossover trial, in which almost three-quarters of patients with mild, persistent asthma were shown to have sputum eosinophil levels below 2%, and the majority of participants did not have a significantly better response to mometasone or tiotropium versus placebo (5:16).

Funding for this video was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Image Credits